Chemotherapy-free treatment shows promise for some patients with metastatic breast cancer

Researchers at the Icahn School of Medicine at Mount Sinai found that a chemotherapy-free combination of four targeted therapies showed encouraging results in patients with HR-positive, HER2-positive metastatic breast cancer, offering a potential first-line treatment option that may be more convenient for some patients and avoids chemotherapy.

Read it at Medical Xpress ↗

← Front page